Your browser doesn't support javascript.
loading
Buprenorphine: a treatment and cause of opioid-induced respiratory depression.
Dahan, Albert; van Lemmen, Maarten; Jansen, Simone; Simons, Pieter; van der Schrier, Rutger.
Afiliação
  • Dahan A; Department of Anesthesiology, Anesthesia & Pain Research Unit, Leiden University Medical Center, Leiden, the Netherlands. Electronic address: a.dahan@lumc.nl.
  • van Lemmen M; Department of Anesthesiology, Anesthesia & Pain Research Unit, Leiden University Medical Center, Leiden, the Netherlands.
  • Jansen S; Department of Anesthesiology, Anesthesia & Pain Research Unit, Leiden University Medical Center, Leiden, the Netherlands.
  • Simons P; Department of Anesthesiology, Anesthesia & Pain Research Unit, Leiden University Medical Center, Leiden, the Netherlands.
  • van der Schrier R; Department of Anesthesiology, Anesthesia & Pain Research Unit, Leiden University Medical Center, Leiden, the Netherlands.
Br J Anaesth ; 128(3): 402-404, 2022 03.
Article em En | MEDLINE | ID: mdl-34996591
ABSTRACT
Buprenorphine is a partial agonist at the mu opioid receptor. Due to its relatively low maximum effect on respiratory depression it is considered by some to be a safe opioid. But it can produce serious respiratory depression, particularly when combined with sedatives such as benzodiazepines.
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Insuficiência Respiratória / Buprenorfina Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Insuficiência Respiratória / Buprenorfina Idioma: En Ano de publicação: 2022 Tipo de documento: Article